Genome-wide aberrant DNA methylation of microRNA host genes in hepatocellular carcinoma

Epigenetics

Volumn 7, Issue 11, 2012, Pages 1230-1237

  Shen, Jing ^a   Wang, Shuang ^a   Zhang, Yu Jing ^a   Kappil, Maya A ^a   Wu, Hui Chen ^a   Kibriya, Muhammad G ^b   Wang, Qiao ^a   Jasmine, Farzana ^b   Ahsan, Habibul ^b   Lee, Po Huang ^c   Yu, Ming Whei ^d   Chen, Chien Jen ^d,e   Santella, Regina M ^a  

^a Mailman School of Public Health of Columbia University ^*  (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e GENOMICS RESEARCH CENTER   (Taiwan)

Author keywords

DNA methylation; Genome wide; HCC; Host gene; MicroRNA

Indexed keywords

EID: 84868348620     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.22140     Document Type: Article

References (59)

1. Jemal A., Bray F., Center M.M, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61:69-90. PMID:21296855; http://dx.doi.org/10.3322/caac.20107.
2. Chuang SC, La Vecchia C, Boffetta P. Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection. Cancer Lett 2009; 286:9-14. PMID:19091458; http://dx.doi.org/10.1016/j.canlet.2008.10.040.
3. Mínguez B, Lachenmayer A. Diagnostic and prognostic molecular markers in hepatocellular carcinoma. Dis Markers 2011; 31:181-190. PMID:22045404.
4. Yasen M, Obulhasim G, Kajino K, Mogushi K, Mizushima H, Tanaka S, et al. DNA binding protein A expression and methylation status in hepatocellular carcinoma and the adjacent tissue. Int J Oncol 2012;40:789-797. PMID:22159460.
5. Pereira B, Oliveira C, David L, Almeida R. CDX2 promoter methylation is not associated with mRNA expression. Int J Cancer 2009; 125:1739-1742. PMID:19569237; http://dx.doi.org/10.1002/ijc.24544.
6. Shah N, Lin B, Sibenaller Z, Ryken T, Lee H, Yoon JG, et al. Comprehensive analysis of MGMT promoter methylation: correlation with MGMT expression and clinical response in GBM. PLoS One 2011; 6:e16146. PMID:21249131; http://dx.doi.org/10.1371/journal.pone.0016146.
7. Formeister EJ, Tsuchiya M, Fujii H, Shpyleva S, Pogribny IP, Rusyn I. Comparative analysis of promoter methylation and gene expression endpoints between tumorous and non-tumorous tissues from HCV-positive patients with hepatocellular carcinoma. Mutat Res 2010; 692:26-33. PMID:20736025; http://dx.doi.org/10.1016/j.mrfmmm.2010.07.013.
8. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120:15-20. PMID:15652477; http://dx.doi.org/10.1016/j.cell.2004.12.035.
9. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116:281-297. PMID:14744438; http://dx.doi.org/10.1016/S0092-8674(04)00045-5.
10. Pasquinelli AE, Hunter S, Bracht J. MicroRNAs: a developing story. Curr Opin Genet Dev 2005; 15:200-205. PMID:15797203; http://dx.doi.org/10.1016/j.gde.2005.01.002.
11. Carleton M, Cleary MA, Linsley PS. MicroRNAs and cell cycle regulation. Cell Cycle 2007; 6:2127-2132. PMID:17786041; http://dx.doi.org/10.4161/cc.6.17.4641.
12. Garzon R, Calin GA, Croce CM. MicroRNAs in Cancer. Annu Rev Med 2009; 60:167-179. PMID:19630570; http://dx.doi.org/10.1146/annurev.med.59.053006.104707.
13. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6:857-866. PMID:17060945; http://dx.doi.org/10.1038/nrc1997.
14. Braconi C, Patel T. MicroRNA expression profiling: a molecular tool for defining the phenotype of hepatocellular tumors. Hepatology 2008; 47:1807-1809. PMID:18506877; http://dx.doi.org/10.1002/hep.22326.
15. Huang YS, Dai Y, Yu XF, Bao SY, Yin YB, Tang M, et al. Microarray analysis of microRNA expression in hepatocellular carcinoma and non-tumorous tissues without viral hepatitis. J Gastroenterol Hepatol 2008; 23:87-94. PMID:18171346; http://dx.doi.org/10.1111/j.1440-1746.2007.05223.x.
16. Ladeiro Y, Couchy G, Balabaud C, Bioulac-Sage P, Pelletier L, Rebouissou S, et al. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology 2008; 47:1955-1963. PMID:18433021; http://dx.doi.org/10.1002/hep.22256.
17. Gramantieri L, Ferracin M, Fornari F, Veronese A, Sabbioni S, Liu CG, et al. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res 2007; 67:6092-6099. PMID:17616664; http://dx.doi.org/10.1158/0008-5472.CAN-06-4607.
18. Kutay H, Bai S, Datta J, Motiwala T, Pogribny I, Frankel W, et al. Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. J Cell Biochem 2006; 99:671-678. PMID:16924677; http://dx.doi.org/10.1002/jcb.20982.
19. Murakami Y, Yasuda T, Saigo K, Urashima T, Toyoda H, Okanoue T, et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 2006; 25:2537-2545. PMID:16331254; http://dx.doi.org/10.1038/sj.onc.1209283.
20. Wong QW, Lung RW, Law PT, Lai PB, Chan KY, To KF, et al. MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. Gastroenterology 2008; 135:257-269. PMID:18555017; http://dx.doi.org/10.1053/j.gastro.2008.04.003.
21. Li W, Xie L, He X, Li J, Tu K, Wei L, et al. Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma. Int J Cancer 2008; 123:1616-622. PMID:18649363; http://dx.doi.org/10.1002/ijc.23693.
22. Saito Y, Jones PA. Epigenetic activation of tumor suppressor microRNAs in human cancer cells. Cell Cycle 2006; 5:2220-2222. PMID:17012846; http://dx.doi.org/10.4161/cc.5.19.3340.
23. Weber B, Stresemann C, Brueckner B, Lyko F. Methylation of human microRNA genes in normal and neoplastic cells. Cell Cycle 2007; 6:1001-1005. PMID:17457051; http://dx.doi.org/10.4161/cc.6.9.4209.
24. Saito Y, Liang G, Egger G, Friedman JM, Chuang JC, Coetzee GA, et al. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 2006; 9:435-443. PMID:16766263; http://dx.doi.org/10.1016/j.ccr.2006.04.020.
25. Saito Y, Friedman JM, Chihara Y, Egger G, Chuang JC, Liang G. Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells. Biochem Biophys Res Commun 2009; 379:726-731. PMID:19116145; http://dx.doi.org/10.1016/j.bbrc.2008.12.098.
26. Kunej T, Godnic I, Ferdin J, Horvat S, Dovc P, Calin GA. Epigenetic regulation of microRNAs in cancer: an integrated review of literature. Mutat Res 2011; 717:77-84. PMID:21420983; http://dx.doi.org/10.1016/j.mrfmmm.2011.03.008.
27. Alpini G, Glaser SS, Zhang JP, Francis H, Han Y, Gong J, et al. Regulation of placenta growth factor by microRNA-125b in hepatocellular cancer. J Hepatol 2011; 55:1339-1345. PMID:21703189; http://dx.doi.org/10.1016/j.jhep.2011.04.015.
28. Datta J, Kutay H, Nasser MW, Nuovo GJ, Wang B, Majumder S, et al. Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis. Cancer Res 2008; 68:5049-5058. PMID:18593903; http://dx.doi.org/10.1158/0008-5472.CAN-07-6655.
29. Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I, Inazawa J. MiR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 2010; 31:766-776. PMID:19843643; http://dx.doi.org/10.1093/carcin/bgp250.
30. Huang J, Wang Y, Guo Y, Sun S. Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1. Hepatology 2010; 52:60-70. PMID:20578129; http://dx.doi.org/10.1002/hep.23660.
31. Shen J, Wang S, Zhang YJ, Kappil M, Wu HC, Kibriya MG, et al. Genome-wide DNA methylation profiles in hepatocellular carcinoma. Hepatology 2012; 55:1799-1808. PMID:22234943; http://dx.doi.org/10.1002/hep.25569.
32. Shu Y, Wang B, Wang J, Wang JM, Zou SQ. Identification of methylation profile of HOX genes in extrahepatic cholangiocarcinoma. World J Gastroenterol 2011; 17:3407-3419. PMID:21876633; http://dx.doi.org/10.3748/wjg.v17.i29.3407.
33. Waltering KK, Porkka KP, Jalava SE, Urbanucci A, Kohonen PJ, Latonen LM, et al. Androgen regulation of micro-RNAs in prostate cancer. Prostate 2011; 71:604-614. PMID:20945501; http://dx.doi.org/10.1002/pros.21276.
34. Han L, Witmer PD, Casey E, Valle D, Sukumar S. DNA methylation regulates MicroRNA expression. Cancer Biol Ther 2007; 6:1284-1288. PMID:17660710.
35. Matsushima K, Isomoto H, Kohno S, Nakao K. MicroRNAs and esophageal squamous cell carcinoma. Digestion 2010; 82:138-144. PMID:20588024; http://dx.doi.org/10.1159/000310918.
36. Hui AB, Lenarduzzi M, Krushel T, Waldron L, Pintilie M, Shi W, et al. Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas. Clin Cancer Res 2010; 16:1129-1139. PMID:20145181; http://dx.doi.org/10.1158/1078-0432.CCR-09-2166.
37. Shen YL, Jiang YG, Greenlee AR, Zhou LL, Liu LH. MicroRNA expression profiles and miR-10a target in anti-benzo[a] pyrene-7, 8-diol-9, 10-epoxidetransformed human 16HBE cells. Biomed Environ Sci 2009; 22:14-21. PMID:19462682; http://dx.doi.org/10.1016/S0895-3988(09)60016-7.
38. Tan Y, Zhang B, Wu T, Skogerbø G, Zhu X, Guo X, et al. Transcriptional inhibiton of Hoxd4 expression by miRNA-10a in human breast cancer cells. BMC Mol Biol 2009; 10:12. PMID:19232136; http://dx.doi.org/10.1186/1471-2199-10-12.
39. Agirre X, Jiménez-Velasco A, San José-Enériz E, Garate L, Bandrés E, Cordeu L, et al. Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+cells increases USF2-mediated cell growth. Mol Cancer Res 2008; 6:1830-1840. PMID:19074828; http://dx.doi.org/10.1158/1541-7786.MCR-08-0167.
40. Abe M, Hamada J, Takahashi O, Takahashi Y, Tada M, Miyamoto M, et al. Disordered expression of HOX genes in human non-small cell lung cancer. Oncol Rep 2006; 15:797-802. PMID:16525661.
41. Zhang X, Zhu T, Chen Y, Mertani HC, Lee KO, Lobie PE. Human growth hormone-regulated HOXA1 is a human mammary epithelial oncogene. J Biol Chem 2003; 278:7580-7590. PMID:12482855; http://dx.doi.org/10.1074/jbc.M212050200.
42. Mohankumar KM, Xu XQ, Zhu T, Kannan N, Miller LD, Liu ET, et al. HOXA1-stimulated oncogenicity is mediated by selective upregulation of components of the p44/42 MAP kinase pathway in human mammary carcinoma cells. Oncogene 2007; 26:3998-4008. PMID:17213808; http://dx.doi.org/10.1038/sj.onc.1210180.
43. Fang Y, Shi C, Manduchi E, Civelek M, Davies PF. MicroRNA-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro. Proc Natl Acad Sci U S A 2010; 107:13450-1345. PMID:20624982; http://dx.doi.org/10.1073/pnas.1002120107.
44. Qin B, Yang H, Xiao B. Role of microRNAs in endothelial inflammation and senescence. Mol Biol Rep 2012; 39:4509-4518. PMID:21952822; http://dx.doi.org/10.1007/s11033-011-1241-0.
45. Hernando E. MicroRNAs and cancer: role in tumorigenesis, patient classification and therapy. Clin Transl Oncol 2007; 9:155-160. PMID:17403626; http://dx.doi.org/10.1007/s12094-007-0029-0.
46. Ohuchida K, Mizumoto K, Lin C, Yamaguchi H, Ohtsuka T, Sato N, et al. MicroRNA-10a is overexpressed in human pancreatic cancer and involved in its invasiveness partially via suppression of the HOXA1 gene. Ann Surg Oncol 2012; 19:2394-2402. PMID:22407312; http://dx.doi.org/10.1245/s10434-012-2252-3.
47. Foley NH, Bray I, Watters KM, Das S, Bryan K, Bernas T, et al. MicroRNAs 10a and 10b are potent inducers of neuroblastoma cell differentiation through targeting of nuclear receptor corepressor 2. Cell Death Differ 2011; 18:1089-1098. PMID:21212796; http://dx.doi.org/10.1038/cdd.2010.172.
48. Varnholt H, Drebber U, Schulze F, Wedemeyer I, Schirmacher P, Dienes HP, et al. MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma. Hepatology 2008; 47:1223-1232. PMID:18307259; http://dx.doi.org/10.1002/hep.22158.
49. Jiang J, Gusev Y, Aderca I, Mettler TA, Nagorney DM, Brackett DJ, et al. Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin Cancer Res 2008; 14:419-427. PMID:18223217; http://dx.doi.org/10.1158/1078-0432.CCR-07-0523.
50. Vrba L, Garbe JC, Stampfer MR, Futscher BW. Epigenetic regulation of normal human mammary cell type-specific miRNAs. Genome Res 2011; 21:2026-2037. PMID:21873453; http://dx.doi.org/10.1101/gr.123935.111.
51. Li J, Smyth P, Flavin R, Cahill S, Denning K, Aherne S, et al. Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells. BMC Biotechnol 2007; 7:36. PMID:17603869; http://dx.doi.org/10.1186/1472-6750-7-36.
52. Xi Y, Nakajima G, Gavin E, Morris CG, Kudo K, Hayashi K, et al. Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples. RNA 2007; 13:1668-1674. PMID:17698639; http://dx.doi.org/10.1261/rna.642907.
53. Balic M, Pichler M, Strutz J, Heitzer E, Ausch C, Samonigg H, et al. High quality assessment of DNA methylation in archival tissues from colorectal cancer patients using quantitative high-resolution melting analysis. J Mol Diagn 2009; 11:102-108. PMID:19179456; http://dx.doi.org/10.2353/jmoldx.2009.080109.
54. Harbeck N, Nimmrich I, Hartmann A, Ross JS, Cufer T, Grützmann R, et al. Multicenter study using paraffin-embedded tumor tissue testing PITX2 DNA methylation as a marker for outcome prediction in tamoxifen-treated, node-negative breast cancer patients. J Clin Oncol 2008; 26:5036-5042. PMID:18711169; http://dx.doi.org/10.1200/JCO.2007.14.1697.
55. Bai S, Nasser MW, Wang B, Hsu SH, Datta J, Kutay H, et al. MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib. J Biol Chem 2009; 284:32015-32027. PMID:19726678; http://dx.doi.org/10.1074/jbc.M109.016774.
56. Barrett T, Troup DB, Wilhite SE, Ledoux P, Rudnev D, Evangelista C, et al. NCBI GEO: archive for highthroughput functional genomic data. Nucleic Acids Res 2009; 37(Database issue):D885-D890. PMID:18940857; http://dx.doi.org/10.1093/nar/gkn764.
57. Bibikova M, Lin Z, Zhou L, Chudin E, Garcia EW, Wu B, et al. High-throughput DNA methylation profiling using universal bead arrays. Genome Res 2006; 16:383-393. PMID:16449502; http://dx.doi.org/10.1101/gr.4410706.
58. Mi H, Dong Q, Muruganujan A, Gaudet P, Lewis S, Thomas PD. PANTHER version 7: improved phylogenetic trees, orthologs and collaboration with the Gene Ontology Consortium. Nucleic Acids Res 2010; 38(Database issue):D204-D210. PMID:20015972; http://dx.doi.org/10.1093/nar/gkp1019.
59. Zhang YJ, Chen CJ, Lee CS, Haghighi B, Yang GY, Wang LW, et al. Aflatoxin B1-DNA adducts and hepatitis B virus antigens in hepatocellular carcinoma and non-tumorous liver tissue. Carcinogenesis 1991; 12:2247-2252. PMID:1721008; http://dx.doi.org/10.1093/carcin/12.12.2247.